Cargando…
CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells for adoptive therapy
Autores principales: | Su, Shu, Liu, Baorui, Zou, Zhengyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705860/ http://dx.doi.org/10.1186/2051-1426-3-S2-P53 |
Ejemplares similares
-
CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients
por: Su, Shu, et al.
Publicado: (2016) -
Corrigendum: CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients
por: Su, Shu, et al.
Publicado: (2017) -
Efficient CRISPR/Cas9-mediated gene disruption in the tetraploid protist Giardia intestinalis
por: Horáčková, Vendula, et al.
Publicado: (2022) -
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy
por: Chamberlain, Christopher Aled, et al.
Publicado: (2022) -
CRISPR/Cas9-Mediated TERT Disruption in Cancer Cells
por: Wen, Luan, et al.
Publicado: (2020)